Third Recall for Hospira, Inc.'s Symbiq One- and Two-Channel Infusers Issued

MedPage Today -- WASHINGTON -- The FDA has issued a class I recall -- its strictest -- for Symbiq infusion pumps because device failure may prevent patients from receiving life-saving therapy.

MORE ON THIS TOPIC